COVID-19 RNA Based Vaccines and the Risk of Prion Disease

Classen Immunotherapies, Inc., 3637 Rockdale Road, Manchester,MD 21102, E-mail: classen@vaccines.net.J. Bart Classen, MD*Citation: Classen JB. COVID-19 RNA Based Vaccines and the Risk of Prion Disease. Microbiol Infect Dis. 2021; 5(1): 1-3.Research ArticleABSTRACTDevelopment of new vaccine technology has been plagued with problems in the past. The current RNA based SARSCoV-2 vaccines were approved in the USContinue reading “COVID-19 RNA Based Vaccines and the Risk of Prion Disease”